Results
1
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
1 companies
Oryzon Genomics
Market Cap: €207.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.68
7D
0.9%
1Y
39.8%